首页> 美国卫生研究院文献>Biology >COVID-19 Infection Fatality Rate Associated with Incidence—A Population-Level Analysis of 19 Spanish Autonomous Communities
【2h】

COVID-19 Infection Fatality Rate Associated with Incidence—A Population-Level Analysis of 19 Spanish Autonomous Communities

机译:与发病率相关的COVID-19感染死亡率-西班牙19个自治社区的人口水平分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Previous studies have found large variations in the COVID-19 infection fatality rate (IFR). This study hypothesized that IFR would be influenced by COVID-19 epidemic intensity. We tested the association between epidemic intensity and IFR using serological results from a recent large SARS-CoV-2 serosurvey (N = 60,983) in 19 Spanish regions. The infection fatality rate for Spain as a whole was 1.15% and varied between 0.13% and 3.25% in the regions (median 1.07%, IQR 0.69–1.32%). The IFR by region was positively associated with SARS-CoV-2 seroprevalence (rho = 0.54; = 0.0162), cases/100,000 (rho = 0.75; = 0.002), hospitalizations/100,000 (rho = 0.78; = 0.0001), mortality/100,000 (rho = 0.77; = 0.0001) and case fatality rate (rho = 0.49; = 0.0327). These results suggest that the SARS-CoV-2 IFR is not fixed. The Spanish regions with more rapid and extensive spread of SARS-CoV-2 had higher IFRs. These findings are compatible with the theory that slowing the spread of COVID-19 down reduces the IFR and case fatality rate via preventing hospitals from being overrun, and thus allowing better and lifesaving care.
机译:先前的研究发现COVID-19感染死亡率(IFR)差异很大。这项研究假设IFR将受到COVID-19流行强度的影响。我们使用最近在西班牙19个地区进行的大型SARS-CoV-2血清调查(N = 60,983)的血清学结果,测试了流行病强度与IFR之间的关联。整个西班牙的感染病死率为1.15%,在该地区,感染病死率在0.13%和3.25%之间变化(中位数为1.07%,IQR为0.69-1.32%)。 IFR区域与SARS-CoV-2血清阳性率(rho = 0.54; = 0.0162),病例/ 100,000(rho = 0.75; = 0.002),住院/ 100,000(rho = 0.78; = 0.0001),死亡率/ 100,000正相关(rho = 0.77; = 0.0001)和病死率(rho = 0.49; = 0.0327)。这些结果表明,SARS-CoV-2 IFR不固定。 SARS-CoV-2传播更为迅速和广泛的西班牙地区的IFR较高。这些发现与以下理论相吻合:通过防止医院超支,降低COVID-19的传播速度可降低IFR和病死率,从而提供更好和救生的护理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号